Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Attentive Chinese investors realised something unusual was happening on February 14. Dozens of listed firms simultaneously ...

Tilly's struggles despite $51.7M net cash, with declining sales, losses, and store closures. Click here to read why TLYS ...

It's no secret that Home Depot's (NYSE: HD) prospects are guided by home improvement spending, which is led by the housing ...

Chart Industries (NYSE:GTLS – Free Report) had its price target raised by Barclays from $145.00 to $165.00 in a research ...

Chart Industries (NYSE:GTLS – Get Free Report) had its target price cut by Wells Fargo & Company from $215.00 to $214.00 in a ...

Share prices of C3.ai (NYSE: AI) sank after the enterprise artificial intelligence (AI) software company reported its fiscal ...

Q4 2024 Earnings Call Transcript February 28, 2025 Chart Industries, Inc. misses on earnings expectations. Reported EPS is $1 ...

Gas handling company Chart (NYSE:GTLS) in Q4 CY2024, but sales rose 9% year on year to $1.11 billion. On the other hand, the ...

Chart Industries, Inc. (NYSE: GTLS) today reported results for the fourth quarter and full year ended December 31, 2024. Results shown are from continuing operations.

The segment’s EBIT margin expanded to 15.8% ... Fresenius' stake in Fresenius Medical Care (NYSE:FMS) remains a key focus, with potential monetization opportunities closely watched by investors.

However, the gross margin contracted 594 basis points to 76.8%. Marketing expenses jumped 75.6% year over year to $221.1 million, while technology and development expenses increased 77.2% year ...